Avantect Pancreatic Cancer Test clinical trials

Surveillance of Pancreatic Health After Diabetes Diagnosis

This study, called SAFE-D, is looking for a new blood test, Avantect, to find pancreatic cancer early in people newly diagnosed with type 2 diabetes. Early detection can lead to better treatment options. Participants will give blood samples and fill out a questionnaire over 12 months.